Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes
- PMID: 2185108
- DOI: 10.2337/diab.39.5.570
Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes
Abstract
The effect of free fatty acids (FFAs) on insulin binding and action was investigated in isolated rat hepatocytes. Oleic acid (0.4 mM) added to the cells rapidly (within 45 min) reduced insulin binding and degradation (each by 45%; P less than 0.001, n = 7) without changing the apparent receptor affinity. The effect was concentration dependent; a half-maximal inhibitory effect occurred at 0.150 +/- 0.050 mM (mean +/- SE). Oleic acid exerted no effect on insulin binding in energy-depleted (KCN-treated) cells. Oleic, palmitic, stearic, palmitoleic, and eicosapentaenoic acids were equally effective in reducing insulin binding. FFA did not change insulin binding to partially purified insulin receptors, thus excluding a direct effect on the insulin receptor. Furthermore, binding to partially purified receptors from solubilized cells pretreated with 0.2 mM oleic acid was not changed, indicating the effect of FFA in intact cells is on the rate of receptor internalization and/or recycling. Concomitant with the effect on insulin binding, oleic acid elicited a concentration-dependent reduction in nonstimulated cellular [14C]aminoisobutyric acid uptake (AIB; 29 +/- 8%, P less than 0.05) and decreased the maximal effect of insulin (39 +/- 7%, P less than 0.05). Thus, in a concentration-dependent manner, different fatty acids can reduce the number of binding sites for insulin and the degradation of insulin by isolated liver cells. Basal and insulin-stimulated AIB transport was reduced, suggesting the presence of postbinding perturbations. These data suggest that FFA exerts an important modulating effect on insulin action in the liver.
Similar articles
-
Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and obese rats.Diabetes. 1992 Mar;41(3):294-8. doi: 10.2337/diab.41.3.294. Diabetes. 1992. PMID: 1312964
-
Prevention of inhibitory effect of free fatty acids on insulin binding and action in isolated rat hepatocytes by etomoxir.Diabetes. 1991 Jun;40(6):783-6. doi: 10.2337/diab.40.6.783. Diabetes. 1991. PMID: 2040395
-
Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.J Clin Invest. 1994 Feb;93(2):870-6. doi: 10.1172/JCI117042. J Clin Invest. 1994. PMID: 8113418 Free PMC article.
-
Glucocorticoid-induced insulin resistance: the importance of postbinding events in the regulation of insulin binding, action, and degradation in freshly isolated and primary cultures of rat hepatocytes.J Clin Invest. 1982 Apr;69(4):866-75. doi: 10.1172/jci110526. J Clin Invest. 1982. PMID: 7042756 Free PMC article.
-
Unesterified long-chain fatty acids inhibit thyroid hormone binding to the nuclear receptor. Solubilized receptor and the receptor in cultured cells.Eur J Biochem. 1989 Aug 15;183(3):565-72. doi: 10.1111/j.1432-1033.1989.tb21085.x. Eur J Biochem. 1989. PMID: 2776751
Cited by
-
Unsaturated fatty acids activate glycogen phosphorylase in cultured rat hepatocytes.Biochem J. 1991 May 15;276 ( Pt 1)(Pt 1):209-15. doi: 10.1042/bj2760209. Biochem J. 1991. PMID: 2039470 Free PMC article.
-
Dehydroepiandrosterone alters lipid profiles in Zucker rats.Lipids. 2000 Jun;35(6):613-20. doi: 10.1007/s11745-000-0564-4. Lipids. 2000. PMID: 10901422
-
Physiologic hormone administration improves HbA1C in Native Americans with type 2 diabetes: A retrospective study and review of insulin secretion and action.Obes Rev. 2023 Dec;24(12):e13625. doi: 10.1111/obr.13625. Epub 2023 Aug 14. Obes Rev. 2023. PMID: 37580916 Free PMC article. Review.
-
Weight loss therapy improves pancreatic endocrine function in obese older adults.Obesity (Silver Spring). 2008 Jun;16(6):1349-54. doi: 10.1038/oby.2008.226. Epub 2008 Apr 3. Obesity (Silver Spring). 2008. PMID: 18388888 Free PMC article. Clinical Trial.
-
Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2.Front Pharmacol. 2021 Jan 25;11:636533. doi: 10.3389/fphar.2020.636533. eCollection 2020. Front Pharmacol. 2021. PMID: 33569010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical